Investment Magazine – Exclusive
The Yemeni Company for the Manufacture and Trade of Medicines (YEDCO) is preparing to resume its operations at full production capacity on a permanent basis in the coming phase, after overcoming the challenges that had previously impacted its output and led to the absence of some products from the pharmaceutical market.
Dr. Mohammed Al-Tihami, Chairman of the Board, confirmed that YEDCO has moved past the difficulties it faced and is now working to reintroduce its products to the market with high quality standards and a diverse range covering various pharmaceutical categories.
This announcement came during an event hosted by the company on Thursday, where several leading wholesale pharmaceutical clients were invited to witness YEDCO’s operational readiness.
Dr. Murad Al-Hurdi, General Manager of YEDCO, stated that the company's production lines are fully prepared to operate at full capacity, adding that new, advanced products are under development to meet the evolving demands of the pharmaceutical market and provide high-quality medicines to Yemeni consumers.
During a tour of the company’s manufacturing facilities, key clients praised YEDCO’s commitment to maintaining production continuity and upholding high quality standards, recognizing it as the leading national pharmaceutical company in Yemen.
The visitors also expressed satisfaction with the company’s operational readiness and the high level of professionalism they observed, reaffirming their confidence in YEDCO’s ability to meet market needs in line with international quality standards.
Comments